Conduit Pharmaceuticals Limited ("Conduit Pharmaceuticals"), a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development, and Murphy Canyon Acquisition Corp.,
Applauds Leading Independent Proxy Advisory Firm, ISS, For Recommending Stratasys Shareholders vote AGAINST the Acquisition of Desktop Metal Commends Other Stratasys Shareholders for Public Statements Announcing
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute
Abpro is a biotechnology company specializing in the development of next-generation antibody therapies intended to improve the lives of those with life-threatening diseases.The transaction values Abpro at $725 million